ACRV
Acrivon Therapeutics, Inc.
- Latest sale
- $155
- Nov 17 · No plan
- Form 4 sales
- 18
- On record
- Form 144 notices
- 1
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planAug 18 2026
Sold 185 shares at $2.01 ($372)
Miller Mary, Chief Legal Officer
No 10b5-1 planSold 0.2% of holdings ($165k position)82,009 shares leftFiling
- 2 Form 4 saleNo planAug 18 same day
Sold 101 shares at $2.01 ($203)
Peterson Katharine, Chief Accounting Officer
No 10b5-1 planSold 0.6% of holdings ($36k position)18,033 shares leftFirst sale on recordFiling
- 3 Form 4 saleNo planAug 25 +7 days
Sold 14,036 shares at $2.21 ($31k)
Blume-Jensen Peter, President and CEO
No 10b5-1 planSold 0.6% of holdings ($5M position)2.2M shares leftFirst sale on recordFiling
- 4 Form 4 saleNo planNov 17 +84 days
Sold 1,780 shares at $1.45 ($3k)
Blume-Jensen Peter, President and CEO
No 10b5-1 planSold 0.1% of holdings ($3.2M position)2.2M shares leftFiling
- 5 Form 4 saleNo planNov 17 same day
Sold 628 shares at $1.45 ($911)
Devroe Eric, Chief Operating Officer
No 10b5-1 planSold 0.4% of holdings ($212k position)145,721 shares leftFiling
- 6 Form 4 saleNo planNov 17 same day
Sold 416 shares at $1.45 ($603)
Gamelin Erick, Chief Development Officer
No 10b5-1 planSold 0.8% of holdings ($76k position)52,176 shares leftFiling
- 7 Form 4 saleNo planNov 17 same day
Sold 193 shares at $1.45 ($280)
Miller Mary, Chief Legal Officer
No 10b5-1 planSold 0.2% of holdings ($118k position)81,009 shares leftFiling
- 8 Form 4 saleNo planNov 17 same day
Sold 107 shares at $1.45 ($155)
Peterson Katharine, Chief Accounting Officer
No 10b5-1 planSold 0.6% of holdings ($26k position)17,926 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (19)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 | Peterson Katharine | Chief Accounting Officer | Form 4 sale | 107 | $155 | 0.6% | No plan | SEC |
| Nov 17, 2026 | Miller Mary | Chief Legal Officer | Form 4 sale | 193 | $280 | 0.2% | No plan | SEC |
| Nov 17, 2026 | Gamelin Erick | Chief Development Officer | Form 4 sale | 416 | $603 | 0.8% | No plan | SEC |
| Nov 17, 2026 | Devroe Eric | Chief Operating Officer | Form 4 sale | 628 | $911 | 0.4% | No plan | SEC |
| Nov 17, 2026 | Blume-Jensen Peter | President and CEO | Form 4 sale | 1,780 | $3k | 0.1% | No plan | SEC |
| Aug 25, 2026 | Blume-Jensen Peter | President and CEO | Form 4 sale | 14,036 | $31k | 0.6% | No plan | SEC |
| Aug 18, 2026 | Peterson Katharine | Chief Accounting Officer | Form 4 sale | 101 | $203 | 0.6% | No plan | SEC |
| Aug 18, 2026 | Miller Mary | Chief Legal Officer | Form 4 sale | 185 | $372 | 0.2% | No plan | SEC |
| Aug 18, 2026 | Gamelin Erick | Chief Development Officer | Form 4 sale | 400 | $804 | 0.8% | No plan | SEC |
| Aug 18, 2026 | Devroe Eric | Chief Operating Officer | Form 4 sale | 604 | $1k | 0.4% | No plan | SEC |
| Aug 18, 2026 | Masson Kristina | EVP - Business Operations | Form 4 sale | 1,713 | $3k | 0.1% | No plan | SEC |
| Aug 4, 2026 | Levy Adam D. | Chief Financial Officer | Form 4 sale | 1,142 | $2k | 1.7% | No plan | SEC |
| Jul 21, 2026 | Miller Mary | Chief Legal Officer | Form 4 sale | 573 | $1k | 0.7% | No plan | SEC |
| May 1, 2025 | Perceptive Advisors LLC | 10% owner | Form 4 sale | 736,767 | $1M | 19.2% | No plan | SEC |
| Apr 29, 2025 | Perceptive Advisors LLC | 10% owner | Form 4 sale | 1.5M | $2.7M | 28.4% | Unusual | SEC |
| Jun 26, 2023 | Smolokowski Wiaczeslaw | 10% owner | Form 4 sale | 16 | $207 | 0.0% | No plan | SEC |
| Jun 15, 2023 | Nikolaou Anastasis | 10% owner | Form 4 sale | 2,056 | $25k | 0.1% | No plan | SEC |
| Jun 14, 2023 | Chione Ltd | 10% owner | Form 4 sale | 5,893 | $72k | 0.2% | No plan | SEC |
| Jun 12, 2023 | Chione Ltd | 10% Stockholder | Form 144 notice | 219,259 | $2.7M | Notice | SEC |